RESEARCH USE ONLY — Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Human or veterinary use prohibited.
Home · All Peptides · Ipamorelin
nasQ Ipamorelin 10 mg research peptide vial

Ipamorelin

$89.99
Strength
Pack size

View Certificate of Analysis
COA Available Batch Documentation Ships from Canada ≥99.7% Purity
Description+

Ipamorelin is a synthetic pentapeptide and selective growth-hormone secretagogue-receptor (GHS-R) agonist. Supplied as a lyophilized powder, it is intended for in-vitro laboratory research into ghrelin-receptor signaling and growth-hormone release pathways.

Molecular Profile

  • CAS Number170851-70-4
  • Molecular Weight711.9 g/mol
  • Molecular FormulaC38H49N9O5
  • SequenceAib-His-D-2-Nal-D-Phe-Lys-NH₂ (pentapeptide)
  • Purity≥99.7% (HPLC-MS/MS)
  • FormatLyophilized white powder
  • Storage−20°C, desiccated
  • ReconstitutionSterile bacteriostatic water

Research Context

Ipamorelin is studied in the preclinical literature as a selective GH secretagogue acting on the ghrelin / GHS-R pathway, with minimal reported effect on cortisol or prolactin in laboratory models.

Quality Assurance

Every lot is independently tested for identity and purity by SideChain Analytics (HPLC-MS/MS), and a Certificate of Analysis is available for each batch. Produced and shipped from within Canada.

Available exclusively for in-vitro laboratory research. Not a drug, natural health product, or food; not for human or veterinary use, and not evaluated for diagnostic or therapeutic application. Researchers are responsible for compliance with all applicable regulations.

Specifications+
  • CompoundIpamorelin
  • Strength10 mg per vial
  • Pack sizes1 vial · 3 pack · 6 pack
  • AppearanceLyophilized white powder
  • Storage−20°C, protect from light
  • VerificationThird-party HPLC-MS/MS (SideChain Analytics)
  • OriginNorth American made · ships from Canada
Research Applications+

Reported in preclinical, in-vitro literature in the following research areas:

• GHS-R / ghrelin-receptor signaling
• GH-release pathway research
• Receptor-selectivity models
• Peptide secretagogue pharmacology

These are areas of laboratory investigation only. No physiological, clinical, or health outcome is claimed or implied for any use of this compound.

Mechanism of Action+

Ipamorelin has been reported to act as a selective agonist of the growth-hormone secretagogue receptor (GHS-R1a), stimulating GH-release signaling in preclinical models.

Other products you may be interested in